tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RDHL Stock Latest News

RedHill Biopharma Gains FDA Support for Innovative Crohn’s Disease Therapy
Company AnnouncementsRedHill Biopharma Gains FDA Support for Innovative Crohn’s Disease Therapy
13d ago
6K
RDHL
RedHill Biopharma receives positive FDA feedback for RHB-204 in Crohn’s Disease
PremiumThe Fly
RedHill Biopharma receives positive FDA feedback for RHB-204 in Crohn’s Disease
13d ago
RDHL
RedHill Biopharma Initiates Phase 2 Prostate Cancer Study
PremiumCompany Announcements
RedHill Biopharma Initiates Phase 2 Prostate Cancer Study
1M ago
6K
RDHL
RedHill initiates recruitment for expanded Phase 2 opaganib/darolutamide study
PremiumThe Fly
RedHill initiates recruitment for expanded Phase 2 opaganib/darolutamide study
1M ago
RDHL
RedHill Biopharma Secures $10 Million Market Purchase Agreement with Alumni Capital
PremiumCompany Announcements
RedHill Biopharma Secures $10 Million Market Purchase Agreement with Alumni Capital
1M ago
6K
RDHL
RedHill Biopharma Approves Key Resolutions at Annual Meeting
PremiumCompany AnnouncementsRedHill Biopharma Approves Key Resolutions at Annual Meeting
2M ago
6K
RDHL
RedHill Biopharma Secures Warrant Exercise with Price Reduction
Premium
Company Announcements
RedHill Biopharma Secures Warrant Exercise with Price Reduction
3M ago
6K
RDHL
RedHill Biopharma Secures Asset Freeze in Legal Victory Over Kukbo
Premium
Company Announcements
RedHill Biopharma Secures Asset Freeze in Legal Victory Over Kukbo
3M ago
6K
RDHL
RedHill Biopharma secures Kukbo asset freeze after $8.25M favorable court ruling
PremiumThe Fly
RedHill Biopharma secures Kukbo asset freeze after $8.25M favorable court ruling
3M ago
RDHL
RedHill Biopharma Postpones Annual Shareholders Meeting Due to Lack of Quorum
PremiumCompany Announcements
RedHill Biopharma Postpones Annual Shareholders Meeting Due to Lack of Quorum
3M ago
6K
RDHL
RedHill Biopharma Launches H. Pylori Education Program at Gastroenterology Congress
PremiumCompany Announcements
RedHill Biopharma Launches H. Pylori Education Program at Gastroenterology Congress
3M ago
6K
RDHL
RedHill Biopharma Secures Key Chinese Patent for COVID-19 Treatment RHB-107
PremiumCompany Announcements
RedHill Biopharma Secures Key Chinese Patent for COVID-19 Treatment RHB-107
3M ago
6K
RDHL
RedHill Biopharma granted Chinese patent application for COVID-19 treatment
PremiumThe FlyRedHill Biopharma granted Chinese patent application for COVID-19 treatment
3M ago
RDHL
RedHill Biopharma Reports 2024 Financial Results and Strategic Progress
Premium
Company Announcements
RedHill Biopharma Reports 2024 Financial Results and Strategic Progress
3M ago
RDHL
RedHill Biopharma Faces Nasdaq Compliance Challenge
Premium
Company Announcements
RedHill Biopharma Faces Nasdaq Compliance Challenge
4M ago
6K
RDHL
RedHill Biopharma receives non-compliance letter from Nasdaq
PremiumThe Fly
RedHill Biopharma receives non-compliance letter from Nasdaq
4M ago
RDHL
RedHill Biopharma’s Opaganib Shows Promise in Obesity and Diabetes Market Disruption
PremiumCompany Announcements
RedHill Biopharma’s Opaganib Shows Promise in Obesity and Diabetes Market Disruption
4M ago
6K
RDHL
RedHill Biopharma announces publication in journal on Opaganib
PremiumThe Fly
RedHill Biopharma announces publication in journal on Opaganib
4M ago
RDHL
RedHill Biopharma Reports 2024 Financial Results and Strategic Advances
PremiumCompany Announcements
RedHill Biopharma Reports 2024 Financial Results and Strategic Advances
4M ago
6K
RDHL
RedHill Biopharma Announces Board Resignation of Eric Swenden
PremiumCompany AnnouncementsRedHill Biopharma Announces Board Resignation of Eric Swenden
4M ago
6K
RDHL
RedHill Biopharma Announces Agenda for 2025 Annual General Meeting
Premium
Company Announcements
RedHill Biopharma Announces Agenda for 2025 Annual General Meeting
4M ago
6K
RDHL
RedHill Biopharma Announces Annual General Meeting Agenda
Premium
Company Announcements
RedHill Biopharma Announces Annual General Meeting Agenda
4M ago
6K
RDHL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >